Kathrin Dellas
Papers
1
Total Citations
16
H-Index
1
About
Dr. Kathrin Dellas is a leading radiation oncologist whose research focuses on advancing stereotactic body radiation therapy (SBRT) for prostate cancer, with a particular emphasis on hypo-fractionated treatment protocols. Her major contribution lies in demonstrating the feasibility and safety of ultra-hypo-fractionated SBRT for localized prostate cancer, as evidenced by her seminal 2017 study—a German bi-center single treatment group feasibility trial that has garnered 16 citations. This work challenged conventional fractionation schedules by showing that high-dose radiation could be delivered in fewer, more intense sessions without compromising efficacy or increasing toxicity, potentially reducing treatment from weeks to just days. Dr. Dellas’s research has significant implications for patient convenience and healthcare resource utilization, positioning her as a key figure in the shift toward shorter, more accessible radiotherapy regimens. Her findings have helped validate SBRT as a non-invasive alternative to surgery or prolonged radiation, offering patients a precise, outpatient treatment option with minimal side effects. Through her clinical trials and ongoing work, Dr. Dellas continues to shape modern prostate cancer management, bridging the gap between technological innovation and practical, patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1